Literature DB >> 20404328

Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer.

Andrei V Chernov1, Svetlana Baranovskaya, Vladislav S Golubkov, Dustin R Wakeman, Evan Y Snyder, Roy Williams, Alex Y Strongin.   

Abstract

Epigenetic parameters (DNA methylation, histone modifications, and miRNAs) play a significant role in cancer. To identify the common epigenetic signatures of both the individual matrix metalloproteinases (MMPs) and the additional genes, the function of which is also linked to proteolysis, migration, and tumorigenesis, we performed epigenetic profiling of 486 selected genes in unrelated non-migratory MCF-7 breast carcinoma and highly migratory U251 glioma cells. Genome-wide transcriptional profiling, quantitative reverse transcription-PCR, and microRNA analyses were used to support the results of our epigenetic studies. Transcriptional silencing in both glioma and breast carcinoma cells predominantly involved the repressive histone H3 Lys-27 trimethylation (H3K27me3) mark. In turn, epigenetic stimulation was primarily performed through a gain in the histone H3 Lys-4 dimethylation (H3K4me2) and H3 hyperacetylation and by a global reduction of H3K27me3. Inactive pro-invasive genes in MCF-7 cells but not in U251 cells frequently exhibited a stem cell-like bivalent mark (enrichment in both H3K27me3 and H3K4me2), a characteristic of developmental genes. In contrast with other MMPs, MMP-8 was epigenetically silenced in both cell types, thus providing evidence for the strict epigenetic control of this anti-tumorigenic proteinase in cancer. Epigenetic stimulation of multiple collagen genes observed in cultured glioma cells was then directly confirmed using orthotopic xenografts and tumor specimens. We suggest that the epigenetic mechanisms allow gliomas to deposit an invasion-promoting collagen-enriched matrix and then to use this matrix to accomplish their rapid migration through the brain tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404328      PMCID: PMC2885243          DOI: 10.1074/jbc.M109.088153

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly.

Authors:  J Nakayama ; J C Rice; B D Strahl; C D Allis; S I Grewal
Journal:  Science       Date:  2001-03-15       Impact factor: 47.728

Review 2.  Chromatin remodeling enzymes: who's on first?

Authors:  C J Fry; C L Peterson
Journal:  Curr Biol       Date:  2001-03-06       Impact factor: 10.834

3.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

4.  Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin.

Authors:  Antoine H F M Peters; Jacqueline E Mermoud; Dónal O'Carroll; Michaela Pagani; Dieter Schweizer; Neil Brockdorff; Thomas Jenuwein
Journal:  Nat Genet       Date:  2001-12-10       Impact factor: 38.330

Review 5.  Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails.

Authors:  Y Zhang; D Reinberg
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

6.  Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.

Authors:  Elena I Deryugina; Liliana Soroceanu; Alex Y Strongin
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

7.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.

Authors:  A J Bannister; P Zegerman; J F Partridge; E A Miska; J O Thomas; R C Allshire; T Kouzarides
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

8.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.

Authors:  M Lachner; D O'Carroll; S Rea; K Mechtler; T Jenuwein
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

9.  Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.

Authors:  A C Poncelet; H W Schnaper
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

Review 10.  MicroRNAs in Cancer.

Authors:  Ramiro Garzon; George A Calin; Carlo M Croce
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

View more
  29 in total

Review 1.  Fetal hypoxia and programming of matrix metalloproteinases.

Authors:  Wenni Tong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

Review 2.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

3.  Intradomain cleavage of inhibitory prodomain is essential to protumorigenic function of membrane type-1 matrix metalloproteinase (MT1-MMP) in vivo.

Authors:  Vladislav S Golubkov; Andrei V Chernov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

4.  Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival.

Authors:  W B Pope; L Mirsadraei; A Lai; A Eskin; J Qiao; H J Kim; B Ellingson; P L Nghiemphu; S Kharbanda; R H Soriano; S F Nelson; W Yong; H S Phillips; T F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

5.  Association of collagen architecture with glioblastoma patient survival.

Authors:  Kelli B Pointer; Paul A Clark; Alexandra B Schroeder; M Shahriar Salamat; Kevin W Eliceiri; John S Kuo
Journal:  J Neurosurg       Date:  2016-09-02       Impact factor: 5.115

Review 6.  COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.

Authors:  Fernando Vázquez-Villa; Marcos García-Ocaña; José A Galván; Jorge García-Martínez; Carmen García-Pravia; Primitiva Menéndez-Rodríguez; Carmen González-del Rey; Luis Barneo-Serra; Juan R de Los Toyos
Journal:  Tumour Biol       Date:  2015-03-12

7.  Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures.

Authors:  Carsten Hagemann; Jelena Anacker; Stefanie Haas; Daniela Riesner; Beate Schömig; Ralf-Ingo Ernestus; Giles H Vince
Journal:  BMC Res Notes       Date:  2010-11-10

8.  Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake.

Authors:  Brock C Christensen; Karl T Kelsey; Shichun Zheng; E Andres Houseman; Carmen J Marsit; Margaret R Wrensch; Joseph L Wiemels; Heather H Nelson; Margaret R Karagas; Lawrence H Kushi; Marilyn L Kwan; John K Wiencke
Journal:  PLoS Genet       Date:  2010-07-29       Impact factor: 5.917

9.  Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.

Authors:  Justin S Ko; Kelly A Eddinger; Mila Angert; Andrei V Chernov; Jennifer Dolkas; Alex Y Strongin; Tony L Yaksh; Veronica I Shubayev
Journal:  Brain Behav Immun       Date:  2016-03-09       Impact factor: 7.217

10.  High-Throughput Multiplexed Peptide-Centric Profiling Illustrates Both Substrate Cleavage Redundancy and Specificity in the MMP Family.

Authors:  Muskan Kukreja; Sergey A Shiryaev; Piotr Cieplak; Norihito Muranaka; David A Routenberg; Andrei V Chernov; Sonu Kumar; Albert G Remacle; Jeffrey W Smith; Igor A Kozlov; Alex Y Strongin
Journal:  Chem Biol       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.